| PCLIX | PCLNX | PCLIX / PCLNX | |
| Total Expense Ratio | 0.82 | 0.97 | 85% |
| Annual Report Gross Expense Ratio | 0.98 | 1.18 | 83% |
| Fund Existence | 16 years | 8 years | - |
| Gain YTD | 6.691 | 6.599 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 4.8B | 4.8B | 100% |
| Annual Yield % from dividends | 4.68 | 4.67 | 100% |
| Returns for 1 year | 8.16 | 8.10 | 101% |
| Returns for 3 years | 15.60 | 15.06 | 104% |
| Returns for 5 years | 105.98 | 104.82 | 101% |
| Returns for 10 years | 154.92 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GQEFX | 35.42 | 0.07 | +0.20% |
| GMO Quality IV | |||
| CGJAX | 75.55 | 0.10 | +0.13% |
| Calvert US Large Cap Growth Rspnb Idx A | |||
| JIESX | 20.50 | 0.01 | +0.05% |
| JPMorgan Developed International Value I | |||
| VICVX | 22.62 | -0.01 | -0.04% |
| USA Mutuals Vice Institutional | |||
| ITETX | 10.34 | -0.15 | -1.43% |
| VY® T. Rowe Price Equity Income S2 | |||